| Previous Close | 146.71 |
| Open | 146.39 |
| Bid | 140.00 x 200 |
| Ask | 144.00 x 200 |
| Day's Range | 140.50 - 148.50 |
| 52 Week Range | 36.71 - 192.94 |
| Volume | 875,629 |
| Avg. Volume | 1,162,539 |
| Market Cap | 7.6B |
| Beta | 2.36 |
| PE Ratio (TTM) | -16.55 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Motley Fool•yesterday
How Things Look for Opko Health, Inc. in 3 Charts
It hasn't been a great year so far for Opko Health, but the future could be brighter.
- Investor's Business Daily•7 days ago
Could Tesaro Overcome Clovis' Lead On Combos With Merck & Co.?
Tesaro's Zejula would likely outperform drugs from Clovis and AstraZeneca in immuno-oncology combinations with Merck, Bristol or Roche.
- Barrons.com•7 days ago
Biotech ETFs: Still Riding High
The biotechnology-stock rally continues. The SPDR S&P Biotech (XBI) and the iShares Nasdaq Biotechnology (IBB), among the highest-flying exchange-traded funds yesterday, both hit their 52-week highs on ...
